Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits

Journal of Immunological Methods

Volumn 299, Issue 1-2, 2005, Pages 153-164

  Ashby, Deborah ^a   Leduc, Isabelle ^a   Lauzon, Wallace ^a   Craig Lee, B ^a,b   Singhal, Neera ^c   Cameron, D William ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Animal model; Attenuated Salmonella; Chancroid vaccine; Haemophilus ducreyi; Recombinant antigens

Indexed keywords

HAEMOPHILUS VACCINE; LIVE VACCINE; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; SL 3261; TETANUS ANTIBODY; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPERIMENTAL MODEL; EXPRESSION VECTOR; GENETIC TRANSDUCTION; HAEMOPHILUS DUCREYI; IMMUNITY; IMMUNOGENICITY; INOCULATION; MALE; MONITORING; NONHUMAN; PLASMID; PRIORITY JOURNAL; RABBIT; SALMONELLA TYPHIMURIUM; TEMPERATURE DEPENDENCE; ULCUS MOLLE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; CHANCROID; GENETIC VECTORS; HAEMOPHILUS DUCREYI; MALE; PLASMIDS; RABBITS; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; TETANUS TOXIN; VACCINES, ATTENUATED;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS DUCREYI; ORYCTOLAGUS CUNICULUS; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 19444363977     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.02.005     Document Type: Article

References (51)

1. R.J. Anderson, L.P. Londoño, D.J. Pickard, and G. Dougan Development of attenuated Salmonella strains that express heterologous antigens A. Robinson G.H. Farrar C.N. Wiblinp Vaccine Protocols 1996 Humana Press Totowa, NJ 47
2. J. Benyacoub, S. Hopkins, A. Potts, S. Kelly, J.P. Kraehenbuhl, R. Curtiss III, P. De Grandi, and D. Nardelli-Haefliger The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice Infect. Immun. 67 1999 3674
3. BioRadLaboratories Mini-protean II Dual Slab Cell Instruction Manual 1987 BioRad Laboratories Richmond, CA
4. E.C. Boedeker, H.S. Houng, D. Hone, L.Y. Tseng, M. Wolf, and C. McQueen Assessment of attenuated Salmonella typhimurium strains designed as potential carriers of foreign antigens for mucosal localization and immuno-genicity in a rabbit model Adv. Exp. Med. Biol. 7 1995 1653
5. L.R. Bullas, and J.I. Ryu Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification J. Bacteriol. 156 1983 471
6. D.W. Cameron, and N.S. Padian Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases Aids 4 1990 S99
7. D.W. Cameron, J.N. Simonsen, L.J. D'Costa, A.R. Ronald, G.M. Maitha, M.N. Gakinya, M. Cheang, J.O. Ndinya-Achola, P. Piot, and R.C. Brunham Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men Lancet 2 1989 403
8. S. Chatfield, M. Roberts, J. Li, A. Starns, and G. Dougan The use of live attenuated Salmonella for oral vaccination Dev. Biol. Stand. 82 1994 35
9. H. Chen, and D.M. Schifferli Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains Infect. Immun. 68 2000 3129
10. J.K. Choi, S.H. Yoon, H.Y. Hong, D.K. Choi, and G.S. Yoo A modified Coomassie blue staining of proteins in polyacrylamide gels with Bismark brown R Anal. Biochem. 236 1996 82
11. M. Desjardins, C.E. Thompson, L.G. Filion, J.O. Ndinya-Achola, F.A. Plummer, A.R. Ronald, P. Piot, and D.W. Cameron Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi J. Clin. Microbiol. 30 1992 2019
12. M. Desjardins, L.G. Filion, S. Robertson, and D.W. Cameron Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease Infect. Immun. 63 1995 2012
13. M. Desjardins, L.G. Filion, S. Robertson, L. Kobylinski, and D.W. Cameron Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid Infect. Immun. 64 1996 1778
14. G. Dougan, C.E. Hormaeche, and D.J. Maskell Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system Parasite Immunol. 9 1987 151
15. S.J. Dunstan, C.P. Simmons, and R.A. Strugnell Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen Infect. Immun. 66 1998 732
16. R.A. Giannella, S.A. Broitman, and N. Zamcheck Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro Gut 13 1972 251
17. O.G. Gomez-Duarte, D. Bumann, and T.F. Meyer The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases Vaccine 17 1999 1667
18. C. Gonzalez, D. Hone, F.R. Noriega, C.O. Tacket, J.R. Davis, G. Losonsky, J.P. Nataro, S. Hoffman, A. Malik, and E. Nardin Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans J. Infect. Dis. 169 1994 927
19. G.W. Hammond, C.J. Lian, J.C. Wilt, and A.R. Ronald Antimicrobial susceptibility of Haemophilus ducreyi Antimicrob. Agents Chemother. 13 1978 608
20. D.E. Hanes, M.G. Robl, C.M. Schneider, and D.H. Burr New Zealand white rabbit as a nonsurgical experimental model for Salmonella enterica gastroenteritis Infect. Immun. 69 2001 6523
21. J.A. Harrison, B. Villarreal-Ramos, P. Mastroeni, R. Demarco de Hormaeche, and C.E. Hormaeche Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model Immunology 90 1997 618
22. S.K. Hoiseth, and B.A. Stocker Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines Nature 291 1981 238
23. H.S. Hsu Pathogenesis and immunity in murine salmonellosis Microbiol. Rev. 53 1989 390
24. C.A. Ison, J.A. Dillon, and J.W. Tapsall The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi Lancet 351 1998 8
25. B.D. Jones, and S. Falkow Salmonellosis: host immune responses and bacterial virulence determinants Annu. Rev. Immunol. 14 1996 533
26. C.N. Kotton, and E.L. Hohmann Enteric pathogens as vaccine vectors for foreign antigen delivery Infect. Immun. 72 2004 5535
27. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680
28. I. Leduc-Molla, C. Elkins, B. Olsen, and D.W. Cameron rHgba, a recombinant hemoglobin-binding receptor of Haemophilus ducreyi, is a possible vaccinogen against the genital ulcer disease chancroid Thirteenth Meeting of the International Society of Sexually Transmitted Diseases Research Abstract Guide, Abstract #327 1999 186
29. J.J. Lee, K.A. Sinha, J.A. Harrison, R.D. de Hormaeche, G. Riveau, R.J. Pierce, A. Capron, R.A. Wilson, and C.M. Khan Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase Infect. Immun. 68 2000 2503
30. M.M. Levine, C.O. Tacket, J.E. Galen, E.M. Barry, F.R. Noriega, and M.B. Sztein Progress in development of new attenuated strains of Salmonella typhi as live oral vaccines against typhoid fever New Generation Vaccines 1997 Marcel Dekker Inc. New York 437
31. W.F. Lo, H. Ong, E.S. Metcalf, and M.J. Soloski T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules J. Immunol. 162 1999 5398
32. M.J. Orbach, and E.N. Jackson Transfer of chimeric plasmids among Salmonella typhimurium strains by P22 transduction J. Bacteriol. 149 1982 985
33. N. Orr, J.E. Galen, and M.M. Levine Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA Infect. Immun. 67 1999 4290
34. M.D. Oxer, C.M. Bentley, J.G. Doyle, T.C. Peakman, I.G. Charles, and A.J. Makoff High level heterologous expression in E. coli using the anaerobically-activated nirB promoter Nucleic Acids Res. 19 1991 2889
35. D.W. Pascual, R.J. Powell, G.K. Lewis, and D.M. Hone Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine Behring-Inst.-Mitt. 1997 143
36. B.K. Purcell, J.A. Richardson, J.D. Radolf, and E.J. Hansen A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi J. Infect. Dis. 164 1991 359
37. L.R. San Mateo, K.L. Toffer, P.E. Orndorff, and T.H. Kawula Immune cells are required for cutaneous ulceration in a swine model of chancroid Infect. Immun. 67 1999 4963
38. J.N. Simonsen, D.W. Cameron, M.N. Gakinya, J.O. Ndinya-Achola, L.J. D'Costa, P. Karasira, M. Cheang, A.R. Ronald, P. Piot, and F.A. Plummer Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa N. Engl. J. Med. 319 1988 274
39. J.C. Sirard, F. Niedergang, and J.P. Kraehenbuhl Live attenuated Salmonella: a paradigm of mucosal vaccines Immunol. Rev. 171 1999 5
40. E.A. Somner, S.A. Ogun, K.A. Sinha, L.M. Spencer Valero, J.J. Lee, J.A. Harrison, A.A. Holder, C.E. Hormaeche, and C.M. Khan Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains Microbiology 145 1999 221
41. S.M. Spinola, L.M. Wild, M.A. Apicella, A.A. Gaspari, and A.A. Campagnari Experimental human infection with Haemophilus ducreyi J. Infect. Dis. 169 1994 1146
42. R. Steen Eradicating chancroid Bull. World Health Organ. 79 2001 818
43. R. Steen, B. Vuylsteke, T. DeCoito, S. Ralepeli, G. Fehler, J. Conley, L. Bruckers, G. Dallabetta, and R. Ballard Evidence of declining STD prevalence in a South African mining community following a core-group intervention Sex. Transm. Dis. 27 2000 1
44. K.L. Thomas, I. Leduc, B. Olsen, C.E. Thomas, D.W. Cameron, and C. Elkins Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi Infect. Immun. 69 2001 4438
45. D.L. Trees, and S.A. Morse Chancroid and Haemophilus ducreyi: an update Clin. Microbiol. Rev. 8 1995 357
46. C.M. Tsai, and C.E. Frasch A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels Anal. Biochem. 119 1982 115
47. M. Tuffrey, D. Abeck, F. Alexander, A.P. Johnson, R.C. Ballard, and D. Taylor-Robinson A mouse model of Haemophilus ducreyi infection (chancroid) FEMS Microbiol. Lett. 50 1988 207
48. M. Tuffrey, F. Alexander, R.C. Ballard, and D. Taylor-Robinson Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi J. Exp. Pathol. (Oxford) 71 1990 233
49. J.L. Vancott, M. Kweon, K. Fujihashi, M. Yamamoto, M. Marinaro, H. Kiyono, and J.R. McGhee Helper T subsets and cytokines for mucosal immunity and tolerance Behring-Inst.-Mitt. 1997 44
50. L. Wang, H. Curd, and P.R. Reeves Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen Microb. Pathog. 27 1999 55
51. S.J. Ward, G. Douce, D. Figueiredo, G. Dougan, and B.W. Wren Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A Infect. Immun. 67 1999 2145